biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI tweets:

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon May 16, 2023 2:58pm

95 Views

Post# 35450874

RE:BTI tweets:

Bwahhhhh hahahahahahaha!!!!

Get out of Dodge, poof!!

The Tweet says, "...our team is leveraging our xB3 platform to develop novel therapies that can cross the blood-brain barrier & provide hope to patients in need."

That's pure nonsense, hyperbole, from a blatherskite. Pure hyperbole.

Bioasis doesn't have enough money to leverage anything more than a free post on Twitter.

What a stupid thing for Bioasis to Tweet! The evidence is the exact opposite.

But Trader Poof likes it, of course.

jd

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload